We exhibit that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD capabilities in a number of human and mouse immune cells; we provide proof in their ability to suppress inflammation in vivo and in scientific configurations; and we provide insights into their mechanism of action. Our conclusions establish SLC15A4 https://georgen420gpw7.eedblog.com/profile